The Department of Justice got it just right when it focused its challenge to Anthem’s acquisition of Cigna and Aetna’s acquisition of Humana on the harm to quality and innovation in health care. DOJ echoed the exact arguments we made repeatedly before antitrust officials, Congress and others about how these mega-deals threatened consumers. The proposed deals would have reduced the number of commercial health insurance giants from five to three – just three companies covering nearly 44% of insured Americans, with nearly $345 billion in revenue. That might be good for the bottom lines of these companies – but not for consumers, who would have faced fewer choices for coverage at higher costs. Hospitals are eager to partner with others, including insurers, to transform care by making it more responsive to the needs of consumers. We hope DOJ’s decision encourages insurers to partner with us in building a better, more durable continuum of care for the people we serve. 

Related News Articles

Headline
The National Institutes of Health yesterday awarded grants to five new projects through its Health Care Systems Research Collaboratory, which conducts clinical…
Insights and Analysis
Plus: Specialists on call at the Mayo Clinic and health insurers are building patient profiles based on socioeconomic data.
Insights and Analysis
Older adults have complex and unique health needs, which can make their medical care more challenging.
Blog
Headline
The House last night voted 230 to 185 to approve the Standard Merger and Acquisition Reviews Through Equal Rules Act (H.R. 5645), AHA-supported legislation…
Insights and Analysis
The challenge of aligning with government payment models often hampers progress, but alternate care systems have potential to ally incentives and coordinate…